Design, implementation, and evaluation at entry of a prospective cohort study of homosexual and bisexual HIV-1-negative men in Belo Horizonte, Brazil: Project Horizonte
M. Carneiro et al., Design, implementation, and evaluation at entry of a prospective cohort study of homosexual and bisexual HIV-1-negative men in Belo Horizonte, Brazil: Project Horizonte, J ACQ IMM D, 25(2), 2000, pp. 182-187
Background and Objectives: Project Horizonte, an open cohort of homosexual
and bisexual HIV-l-negative men, is a component of the Minas Gerais AIDS Va
ccine Program of the Federal University of Minas Gerais, Belo Horizonte, Br
azil. Its objectives included the evaluation of seroincidence of HIV, to as
certain the role of counseling on behavior modification and to assess their
willingness to participate in future HIV vaccine trials.
Methods: Various means of recruitment were used, including pamphlets, notic
es in community newspapers, radio, and television, at anonymous testing cen
ters;, and by word of mouth.
Results: From October 1994 to May 1999, 470 volunteers were enrolled, Their
mean age was 26 years and over 70% of them had high school or college educ
ation. During the follow-up, they were seen every 6 months, when they recei
ved counseling and condoms, and when HIV testing was done. Eighteen serocon
versions were observed, and the incidence rates estimates were 1.75 per 100
and 1.99 per 100 person years, for 36 and 48 months of follow-up, respecti
vely. During the entire period, 139 volunteers were lost to follow-up. Amon
g them, 59 (42.4%) never returned after the initial visit and 51 (36.7) cam
e only once after their initial visit. No losses were observed for those ob
served during follow-up for more than 3 years. At enrollment, 50% of partic
ipants said they would participate in a vaccine trial, and 30% said they mi
ght participate.
Conclusions: The results obtained up to this moment confirm the feasibility
of following this type of cohort for an extended period, estimating HIV in
cidence rate, and evaluating counseling for safe sexual practices in prepar
ation for clinical trials with candidate HIV vaccines in Brazil.